Prival M J, Dunkel V C
Genetic Toxicology Branch, Food and Drug Administration, Washington, DC 20204.
Environ Mol Mutagen. 1989;13(1):1-24. doi: 10.1002/em.2850130102.
An accurate determination of the correlation between the carcinogenicity and the mutagenicity of chemicals has been hampered by the lack of a well-documented list of noncarcinogens. To overcome this problem, Shelby and Stasiewicz (Environ Mutagen 6:871-878, 1984) published a list of 70 chemicals that showed no evidence of carcinogenicity in the National Cancer Institute (NCI) or National Toxicology Program (NTP) rodent carcinogenesis bioassays. More recently, Tennant et al. (Science 236:933-941, 1987) published a list of chemicals, including 29 noncarcinogens, that had been adequately tested for carcinogenicity by the NTP. Of the chemicals listed by Shelby and Stasiewicz or by Tennant and co-workers as noncarcinogenic, the NTP has evaluated 25 as mutagenic in Salmonella typhimurium; 48 of the noncarcinogens were evaluated as nonmutagenic. Thus, of the 73 noncarcinogens that have been evaluated as either positive or negative for mutagenicity, 34% (25/73) were "false positives" (mutagenic noncarcinogens) in the S. typhimurium assay. We re-evaluated the same mutagenicity and carcinogenicity data to determine whether the frequency of "false positives" is really as high as it appears to be. Our reevaluation of the mutagenicity data used more stringent criteria for calling a compound mutagenic than those used by the NTP, resulting in a substantial reduction in the frequency of "false positives" in the S. typhimurium mutagenicity assay. However, application of these same stringent criteria also substantially reduced the frequency of "true positives" (mutagenic carcinogens). Thus, it is concluded that modification of the evaluation criteria for the mutagenicity test can increase the specificity of the assay for the detection of carcinogens, but only at the cost of a corresponding reduction in sensitivity. We also performed a separate reevaluation of the NCI/NTP carcinogenicity data for the 25 S. typhimurium "false positives," assuming that the NTP evaluations of the mutagenicity data were correct. These reevaluations were based on the methodologies and findings of Griesemer and Cueto (In Montesano R, Bartsch H, Tomatis L (eds): Molecular and Cellular Aspects of Carcinogen Screening Tests.(ABSTRACT TRUNCATED AT 400 WORDS)
由于缺乏一份记录完善的非致癌物清单,准确确定化学物质的致癌性与致突变性之间的相关性受到了阻碍。为克服这一问题,谢尔比和斯塔西维茨(《环境诱变剂》6:871 - 878,1984年)公布了一份70种化学物质的清单,这些物质在美国国立癌症研究所(NCI)或国家毒理学计划(NTP)的啮齿动物致癌生物测定中未显示出致癌性证据。最近,坦南特等人(《科学》236:933 - 941,1987年)公布了一份化学物质清单,其中包括29种非致癌物,这些物质已由NTP进行了充分的致癌性测试。在谢尔比和斯塔西维茨或坦南特及其同事列为非致癌的化学物质中,NTP已评估其中25种在鼠伤寒沙门氏菌中具有致突变性;48种非致癌物被评估为无致突变性。因此,在已被评估为致突变性阳性或阴性的73种非致癌物中,34%(25/73)在鼠伤寒沙门氏菌试验中为“假阳性”(致突变性非致癌物)。我们重新评估了相同的致突变性和致癌性数据,以确定“假阳性”的频率是否真的如看起来那么高。我们对致突变性数据的重新评估使用了比NTP更严格的判定化合物具有致突变性的标准,这使得鼠伤寒沙门氏菌致突变性试验中“假阳性”的频率大幅降低。然而,应用这些相同的严格标准也大幅降低了“真阳性”(致突变性致癌物)的频率。因此,可以得出结论,修改致突变性测试的评估标准可以提高该检测致癌物的试验的特异性,但代价是相应降低灵敏度。我们还对25种鼠伤寒沙门氏菌“假阳性”的NCI/NTP致癌性数据进行了单独重新评估,假设NTP对致突变性数据的评估是正确的。这些重新评估基于格里塞默和奎托的方法和研究结果(见蒙特萨诺R、巴尔施H、托马蒂斯L(编):致癌物筛选试验的分子和细胞方面。(摘要截于400字)